| |

Preliminary Program |
|
Thursday, September 28, 2006 |
| 10:00 AM - 7:00 PM |
|
Registration |
| 8:00 AM - 1:00 PM |
|
Board Of Directors’ Meeting |
| 12:30 PM - 1:30 PM |
|
Luncheon Symposium |
| 3:00 PM - 5:00 PM |
|
Hands-On Skills Sessions |
| 5:00 PM |
|
Adjourn |
| 3:00 PM - 7:00 PM |
|
Exhibit Hall Open |
| 5:00 PM - 7:00 PM |
|
Welcome Reception – Exhibit Hall |
| Friday, September 29, 2006 |
| 6:00 AM - 7:50 AM |
|
Industry Sponsored Satellite Breakfast Program
Issues and Controversies the Management of Prostate Cancer with Hormonal Therapy
Speakers: Herbert Lepor, MD, New York
M. Ray Painter, MD, Denver, CO
Sponsored by a grant from Watson Pharma, Inc.
|
| 7:00 AM - 12:00 PM |
|
Exhibit Hall Open |
| 7:00 AM |
|
Continental Breakfast - Visit Exhibits |
| 8:00 AM |
|
Introduction And Welcome Brian M. Jumper, MD, President New England Section of the American Urological Association |
| 8:15 AM - 9:20 AM |
|
Scientific Session I: Prostate Cancer Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe current areas of clinical research in prostate cancer
- Describe innovative surgical procedures in the management of prostate cancer using laparoscopic techniques
- List current areas of controversy in the management of patients with prostate cancer
|
|
| 8:15 AM |
1. Caution: Biopsy Gleason Sum May Confound Treatment Algorithms for Prostate Cancer Michael Cohen, MD1, John Libertino, MD1, Robert Hanley, MD1, Robin Ruthazer, MS2, Karim Hamawy, MD1, Andrea Sorcini, MD1, Robert Roth, MD1, Ingolf Tuerk, MD, PhD1 1Lahey Clinic Medical Center, Burlington, MA; 2TuftsNew England Medical Center, Boston, MA |
| 8:22 AM |
2. The Value Of Transition Zone (TZ) Biopsy In Patients Undergoing Repeat Prostate Biopsy Mazen Abdelhady, MD, Msc, Ashraf J. Abusamra, MD, FRCSC, Jonathan Izawa, MD, BSc, FRCSC, Donal Downey, MD, FRCPC, Joseph Chin, MD, FRCSC London Health Sciences Centre, University of Western Ontario, London, ON, Canada |
| 8:29 AM |
3. Pathological Analysis of 1849 Prostate Biopsies and Radical Prostatectomies Shahin Tabatabaei, MD, Brian H. Eisner, MD, W. S. McDougal, MD.
Massachusetts General Hospital, Boston, MA |
| 8:36 AM |
4. Laparoscopic Extraperitoneal Ascending Intrafascial Prostatectomy: Prospective Comparison and Initial Report of Intraoperative and Early Oncological Results David Canes, MD, Micah Jacobs, MD, Ingolf A. Tuerk, MD, PhD
Lahey Clinic Medical Center, Boston, MA |
| 8:43 AM |
5. Results of Minimally Invasive Laparoscopic Radical Prostatectomy in Men with Localized Prostate Cancer: Single Surgeon Experience Ketul K. Shah, MD,Mch, Douglas M. Dahl, MD
Massachusetts General Hospital, Boston, MA |
| 8:50 AM |
6V. Cystoscopic Treatment of Ureteral Obstruction Following Robotic-Assisted Laparoscopic Radical Prostatectomy Brian H. Irwin, MD1, Joseph R. Wagner, MD2
1University of Connecticut, West Hartford, CT; 2Hartford Hospital, Hartford, CT; |
| 9:00 AM |
|
Discussion |
| 9:20 AM |
|
Invited Guest Speaker Discarding the Myth of Testosterone and the Risk of Prostate Cancer Abraham Morgentaler, MD Brookline, MA |
| 9:50 AM |
|
Discussion |
| 10:05 AM |
|
Coffee Break Visit Exhibits/posters |
| 10:35 AM - 11:45 AM |
|
Scientific Session II: Bladder And Kidney Cancer
Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe the current areas of research in bladder and kidney cancer
- Describe some of the state of the art therapeutic options for managing patients with bladder and kidney cancer
- List current areas of controversy in the management of patients with bladder and kidney cancer
| |
| 10:35 AM |
7. A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria Boback M. Berookhim, BA, Amanjot S. Sethi, MD, C. Charles Wen, MD, Jing Ciu, Richard K. Babayan, MD, Louis S. Liou, MD
Boston University School of Medicine, Boston, MA |
| 10:42 AM |
8. Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay Barry Stein, MD1, Giora Katz, MD2
1Rhode Island Hospital, Providence, RI, USA; 2LakeShore Urology, Manitowoc, WI; |
| 10:49 AM |
9. Preoperative Biopsy Of Renal Lesions Less Than 4.0 Cm Decreases Nephrectomies Performed For Benign Tumors Jai R. Eswara, BA, Brian H. Eisner, MD, Scott E. Hunter, BA, Anthony M. Samir, MD, Peter F. Hahn, MD, Michael M. Maher, MD, Debra A. Gervais, MD, Peter R. Mueller, MD, Francis J. McGovern, MD
Massachusetts General Hospital, Boston, MA |
| 10:56 AM |
10. Stentless Laparoscopic Partial Nephrectomy with Collecting System Entry Christopher M. Lodowsky, MD, Gjanje Smith, MD, Ralph Zagha, MD, Ingolf Tuerk, MD, PhD
Lahey Clinic Medical Center, Burlington, MA |
| 11:03 AM |
11. Complex Urological Oncological Surgeries can be Performed Using Minimally Invasive Robotic or Laparoscopic Methods with Similar Early Perioperative Results Compared to Conventional Open Methods Tony Mammen, MD1, K.C. Balaji, MD2
1University of Nebraska Medical Center, Omaha, NE; 2University of Massachusetts Memorial Medical Center, Worcester, MA; |
| 11:10 AM |
12. Hand-Assisted Retroperitoneoscopic Live Donor Nephrectomy Sanjaya Kumar, MD, Michael Malone, MD, Stefan Tullius, MD, PhD
Brigham and Women's Hospital, Boston, MA |
| 11:17 AM |
13V. Hand Assisted Retroperitoneal Laparoscopic Live Donor Nephrectomy Sanjaya Kumar, MD, Michael Malone, MD, Stefan Tullius, MD, PhD
Brigham and Women's Hospital, Boston, MA |
| 11:27 AM - 11:45 AM |
|
Discussion |
| 11:45 AM - 12:25 PM |
|
Poster Session I: Prostate And Kidney Cancer Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe current areas of clinical research in prostate and kidney cancer
- Describe state-of-the-art pharmacologic options for managing patients with advanced prostate and kidney cancer
- List current areas of controversy in the management of patients with advanced prostate and kidney cancer
| |
| 11:45 AM |
Viewing Time |
| 12:00 PM |
P1. Diagnostic Accuracy of Standard 6-Core and Extended 12-Core Transrectal Prostate Biopsy Sarah P. Psutkah, BA, Brian H. Eisner, MD, Shahin Tabatabaei, MD, W. S. McDougal, MD
Massachusetts General Hospital, Boston, MA |
| 12:03 PM |
P2. Does PSA Density Predict Positive Prostate Biopsy and Prostate Cancer Aggressiveness? Mazen Abdelhady, MD, MSc, Ashraf J. Abusamra, MD, FRCSC, Donal Downey, MD, FRCPC, Jonathan Izawa, MD, BSc, FRCSC, Joseph Chin, MD, FRCSC
London Health Sciences Centre, University of Western Ontario, London, ON, Canada |
| 12:06 PM |
P3. Improved Survival with Sipuleucel-T (APC8015) in Men with Advanced Prostate Cancer Karim J. Hamawy, MD1, John Libertino, MD,Mark Frohlich, MD2
1Lahey Clinic, Burlington, MA, USA; 2Dendreon Corporation, Seattle, WA, USA; |
| 12:09 PM |
P4. Sunitinib Malate (SU11248) Shows Efficacy in Two Consecutively Conducted Phase II Studies of Patients with Metastatic Renal Cell Carcinoma (RCC) M. Dror Michaelson, MD, PhD1, B.I. Rini, MD2, D.J. George, MD3, B.G. Redman, MD4, G.R. Hudes, MD5, G. Wilding, MD6, R.M. Bukowski, MD2, S.T. Kim, PhD7, I. Chen, PhD7, R.J. Motzer, MD8
1Massachusetts General Hospital, Boston, MA; 2Cleveland Clinic Foundation, Cleveland, OH; 3Duke University, Durham, NC; 4University of Michigan, Ann Arbor, MI; 5Fox Chase Cancer Center, Philadelphia, PA; 6University of Wisconsin, Madison, WI; 7Pfizer, Inc, La Jolla, CA; 8Memorial Sloan-Kettering Cancer Center, New York, NY; |
| 12:12 PM |
P5. Immunologic Effects and Promising Clinical Responses of Autologous Dendritic Cell Vaccine in Combination with Interleukin-2 and Interferon-a-2a in Patients with Metastatic Renal Cell Carcinoma Thomas Schwaab, MD PhD, Todd Crocenzi, MD, Jan Fisher, MS, John Seigne, MB, FRCSI, Marc Ernstoff, MD
Dartmouth-Hitchcock Medical Center, Lebanon, NH |
| 12:15 PM |
|
Discussion |
| 12:25 PM |
|
Adjourn For The Day |
| 12:30 PM - 1:30 PM |
|
Lunch Symposium |
| 1:30 PM |
|
Golf Tournament – Triggs Memorial Golf Course Box Lunch will be provided |
| 2:00 PM - 5:00 PM |
|
Aua Instructional Course |
| 6:00 PM - 7:30 PM |
|
Themed Reception Westin: Narragansett Ballroom |
| 8:00 PM |
|
Trinity Repertory Company A Performance of the Cherry Orchard |
| Saturday, September 30, 2006 |
| 6:00 AM - 7:50 AM |
|
Breakfast Symposium |
| 7:00 AM - 8:00 AM |
|
Young Urologist Breakfast Session |
| 7:00 AM - 1:30 PM |
|
Exhbit Hall Open |
| 7:00 AM |
|
Continental Breakfast - Visit Exhibits |
| 8:00 AM - 9:15 AM |
|
Concurrent Scientific Session III: Female Urology/incontinence Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe current areas of research in voiding dysfunction in women
- Describe treatment options for urinary incontinence with emphasis on surgical procedures and therapeutic outcomes
- List current areas of controversy in the evaluation and management of voiding dysfunction in women
|
|
| 8:00 AM |
14. The Role of Videourodynamics in Assessment of Stress Urinary Incontinence and Its Impact on Choice of Surgical Modality Daniel M. Kaplon, MD, Young Kim, MD
Brown University, Providence, RI |
| 8:07 AM |
15. Low Bladder Compliance is a Risk Factor for Bladder Diverticula and/or Vesico-ureteral Reflux on Fluoroscopic Urodynamic Studies John T. Stoffel, MD, Christopher Lodowsky, MD, John F. Bresette, MD Lahey Clinic, Burlington, MA |
| 8:14 AM |
16. Subjective and Objective Voiding Dysfunction in Grade 4 Cystocele: Analysis of 50 Patients M. Grey Maher, MD1, Arthur Mourtzinos, MD2, Larissa V. Rodriguez, MD3, Shlomo Raz, MD3
1The Urology Center, New Haven, CT; 2The Lahey Clinic, Burlington, MA; 3UCLA, Los Angeles, CA; |
| 8:21 AM |
17. Sutureless Tension Free Transperineal Pelvic Floor Mesh Reconstruction and Continence Repair By a Trocar Guided Approach Mitchell H. Bamberger, MD, MBA1, Alexander Berry, MD, MBA2, David M. Trifilio, PA-C3, Andrea M. Pezzella, MD1, Linda Aronson, RN, ANP1
1Fallon Clinic, Worcester, MA; 2Brigham and Women's Hospital, Boston, MA; 3Saint Vincent Hospital, Worcester, MA; |
| 8:28 AM |
18. The Spiral Sling Salvage Anti-Incontinence Surgery for the Female Patient with Refractory Stress Urinary Incontinence: Surgical Outcome and Satisfaction Determined by Patient Driven Questionnaires Arthur Mourtzinos, MD1, Mary Grey Maher, MD2, Larissa Rodriguez, MD2, Larissa Rodriguez, MD2, Shlomo Raz, MD2
1Lahey Clinic Medical Center, Burlington, MA; 2UCLA Medical Center, Los Angeles, CA; |
| 8:35 AM |
19. Improved Continence rates after Rectus Muscle Transposition in Catheterizable Colonic Urinary Reservoirs: Preliminary Results and Report of a Technique M. Grey Maher, MD1, Arthur Mourtzinos, MD2, Larissa V. Rodriguez, MD3, Shlomo Raz, MD3
1The Urology Center, New Haven, CT; 2The Lahey Clinic, Burlington, MA; 3UCLA, Los Angeles, CA; |
| 8:42 AM |
20V. Robot Assisted Vesico-Vaginal Fistula Repair Joseph R. Wagner, MD, Megan Schimpf, MD, Paul K. Tulikangas, MD, Jeffrey H. Morgenstern, MD
Hartford Hospital/University of Connecticut, Hartford, CT |
| 8:49 AM - 9:15 AM |
|
Discussion |
| 8:00 AM - 9:45 AM |
|
Concurrent Poster Session II: Basic Science
Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe current areas of basic science research in the evaluation of urologic disorders of the prostate, bladder and kidney
- Describe state-of-the-art research techniques currently used in the evaluation of urologic disorders of the prostate, bladder and kidney
- List areas of controversy in the evaluation of urologic disorders of the prostate, bladder and kidney using basic science techniques
|
|
| 8:00 AM |
Viewing Time |
| 8:15 AM |
P6. A Novel Optical Non-Invasive Method To Differentiate Normal Prostate Epithelium From Prostate Cancer: An Ex Vivo Study O. A'Amar, PhD, J. Brahmbhatt, BA, F. Chaves, MD, B. Tiernobb, PhD, S. Arya, MD, A. De las Morenas, MD, L. Liou, MD, PhD, I. Bigio, PhD.
Boston University School of Medicine and Department of Engineering, Boston, MA |
| 8:18 AM |
P7. Increases In Tumor Vascular Permeability After Treatment With PDT In Prostate Cancer Curtis Crane, MD, Bin Chen
Dartmouth Hitchcock, Lebanon, NH |
| 8:21 AM |
P8. The Role of MET Receptor Expression in Prostate Cancer Cell Lines Rohit Garg, MBBS, MPH1, Yan Li, MD, PhD2, Charles Cha, MD1, Alp Sener, MD3, Jonathan Hwang, MD4, Jonathan Walker, MD5, Edward M. Uchio, MD1, Stephen Pautler, MD6.
1Department of Surgery, Yale School of Medicine, New Haven, CT, USA; 2Cancer Center, Sun Yat-Sen University, Guangzhon City, China; 3London Health Sciences Centre, London, ON, Canada; 4Robert Wood Johnson University Hospital, New Brunswick, NJ, USA; 5Department of Surgery at the University of Arizona College of Medicine, Tucson, AZ, USA; 6St. Joseph's Health Care London, St. Joseph's Hospital, London, ON, Canada; |
| 8:24 AM |
P9. Ethanol And Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) Enhance Apoptosis In An Androgen-Independent Human Prostate Cancer Cell Line Jeffrey B. Folsom, MD, Peter A. Holoch, MD, Mark K. Plante, MD, FRCS(C), FACS.
University of Vermont College of Medicine, Burlington, VT |
| 8:27 AM |
P10. Role of Apoptosis Inducing Factor in Prostate Cancer Cell Apoptosis Induced by Cisplatin Wenguang Zhang, PhD1, K.C. Balaji, MD2
1University of Nebraska Medical Center, Omaha, NE; 2University of Massachusetts Memorial Medical Center, Worcester, MA; |
| 8:30 AM |
P11. Treatment with Zinc Specific Chelator TPEN Reverses Zn Induced Resistance to Cisplatin in Prostate Cancer Samuel Sterrett, MD1, Tony Mammen1, Cheng Du, PhD2, K.C. Balaji, MD2
1University of Nebraska Medical Center, Omaha, NE; 2University of Massachusetts Memorial Medical Center, Worcester, MA; |
| 8:33 AM |
P12. Protein Kinase D1 is Associated with Membrane Trafficking of ß-catenin Meena Jaggi, PhD1, K.C. Balaji, MD2
1University of South Dakota, Sioux Falls, SD, USA; 2University of Massachusetts Memorial Medical Center, Worcester, MA; |
| 8:36 AM |
P13. Kinase Domain of Protein Kinase D1 Interacts Directly with ß-catenin Cheng Du, PhD1, Meena Jaggi, PhD2, K.C. Balaji, MD1
1University of Massachusetts Memorial Medical Center, Worcester, MA, USA; 2Universtiy of South Dakota, Sioux Falls, SD; |
| 8:39 AM |
P14. Molecular Detection of Novel Bacteria in Prostate Biopsies Robert C. Eyre, MD1, Bryan Desmarais, BS 2, Jeffrey Steinberg, MD3, Vincent A. Andaloro, MD4, Ann A. Kiessling, Ph.D1
1Beth Israel Deaconess Medical Center, Boston, MA; 2Bedford Research Foundation, Somerville, MA; 3St. Vincent's Hospital, Worcester, MA; 4Lahey Clinic Medical Center, Lexington, MA; |
| 8:42 AM - 9:02 AM |
|
Discussion |
| 9:02 AM |
|
P15. The Use of Spectral And Spatial Analysis to Improve The Utility of Urine Cytology in the Diagnosis of Transitional Cell Carcinoma (TCC) Of The Bladder Rohit Garg, MBBS, MPH1, Cesar Angeletti, MD, PhD2,Yan Li, MD, PhD3, Joseph Renzulli, MD1, Edward M. Uchio, MD1, David L. Rimm, MD, PhD2.
1Department of Surgery, Yale School of Medicine, Yale University, New Haven, CT, USA; 2Department of Pathology, Yale School of Medicine, Yale University, New Haven, CT, USA; 3Cancer Institute, Sun Yat-Sen University, Guangzhon City, China; |
| 9:05 AM |
P16. Identification of the Occurrence and Clinical Significance of Epithelial to Mesenchymal Transition in Bladder Tumors In Vivo Egbert D. Baumgart, MD1, Michael S. Cohen, MD1, Micah A. Jacobs, MD1, Chad Wotkowicz, MD1, Brasil Neto, MD2, Kimberly M. Rieger-Christ, PhD2, John A. Libertino, MD1, Ian C. Summerhayes, PhD2
1Lahey Clinic, Burlington, MA; 2Cell and Molecular Biology Laboratory, R.E. Wise MD Research and Education Institute, Burlington, MA; |
| 9:08 AM |
P17. The RNA-binding Protein IMP3: A Novel Molecular Marker Predicts Progression of Superficial (Ta and T1) Urothelial Carcinomas of Bladder Lioudmila Sitnikova, MD, Gary Mendese, Zhong Jiang, MD
Umass Medical Center, Worcester, MA |
| 9:11 AM |
P18. Erlotinib and bladder cancer: Impact on activation and downstream signaling of the Epidermal Growth Factor Receptor Micah A. Jacobs, MD, Chad Wotkowicz, MD, Egbert D. Baumgart, MD, Brasil Silva Neto, MD, Kimberly M. Rieger-Christ, PhD, John A. Libertino, MD, Ian C. Summerhayes, PhD
Lahey Clinic, Burlington, MA |
| 9:14 AM |
P19. Altered Localization of P120 Catenin in Bladder Cancer is Prognostic for Node Involvement Chad Wotkowicz, MD, Baumgart Egbert, MD, Micah Jacobs, MD, Michael Cohen, MD, Brasil Silva Neto, MD, Kimberly M. Rieger Christ, PhD, John A. Libertino, MD, Ian C. Summerhayes, PhD
Lahey Clinic, Burlington, MA |
| 9:17 AM |
P20. Degradation of Matrix Fibronectin: Does it Affect Attachment of BCG to the Bladder Mucosa? Imbesat Daudi, MD, PhD
Aroostook Urology, Presque Isle, ME |
| 9:20 AM |
P21. Silencing of the NOX4 NADP(H) Oxidase Inhibits Tumor Growth of VHL- Deficient Renal Cancer Cells Jodi Maranchie, MD, Ye Zhan, MS
University of Massachusetts, Worcester, MA |
| 9:23 AM - 9:45 AM |
|
Discussion |
| 9:15 AM - 10:00 AM |
|
Coffee Break – Visit Exhibits/posters |
| 10:00 AM |
|
Invited Guest Speaker From The Aua |
| 10:15 AM - 11:20 AM |
|
Concurrent Scientific Session IV: General (Including BPH, Infertility/impotence) Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe current areas of research in male voiding dysfunction, erectile dysfunction, and infertility
- Describe current medical, minimally-invasive procedural and surgical options for men with lower urinary tract symptoms
- Describe state-of-the-art therapeutic options for managing patients with erectile dysfunction and infertility
|
|
| 10:15 AM |
21. Clinical outcomes of Greenlight Laser (Photoselective Vaporization of the Prostate) for Obstructive Benign Prostatic Hyperplasia Michael R. Hermans, MD, King S. Cofffield, MD Scott and White Clinic, Temple, TX |
| 10:22 AM |
22. Efficacy and Tolerability of Sildenafil in Men With Both Erectile Dysfunction and Lower Urinary Tract Symptoms Jed C. Kaminetsky, MD1, Kevin T. McVary, MD2, Li-Jung Tseng, PhD3, Richard L. Siegel, MD3 1University Urology Associates, New York, NY; 2Feinberg School of Medicine, Northwestern University, Chicago, IL; 3Pfizer Inc, New York, NY; |
| 10:29 AM |
23. Site of Semen Collection and Its Effect on Semen Analysis Parameters Rashmi Shetty, MD, LiAnn Handel, MD, Mark Sigman Brown Medical School, Providence, RI |
| 10:36 AM |
24. Repeat Testicular Sperm Extraction (TESE): Outcome, Clinical Correlates and Complications of Different Intervals between First and Subsequent TESE Hasan M. El-Fakahany, MD1, Andrew S. Nisbet, MD2, Stanton C. Honig, MD3 1Al-Minya Faculty of Medicine, Al-Minya, Egypt; 2University of Connecticut, Farmington, CT; 3Urology Center, University of Connecticut, New Haven and Farmington, CT; |
| 10:43 AM |
25. Relationship of Penile Curvature and Penile Vascular Status in Patients with Peyronie's Disease Andrew S. Nisbet, MD, Stanton C. Honig, MD University of Connecticut, Hartford, CT |
| 10:50 AM |
26V. Robotic-Assisted Laparoscopic Bladder Diverticulectomy Edward G. Myer, MD, Joseph R. Wagner, MD Hartford Hospital/University of Connecticut, Hartford, CT |
| 11:00 AM - 11:20 AM |
|
Discussion |
| 10:15 AM - 11:20 AM |
|
Concurrent Poster Session III: Pediatrics
Educational Objectives:
At the conclusion of this session the participants will be able to:
- Describe current areas of research in pediatric urology
- Describe state-of-the-art therapeutic options for managing
patients with common and complex pediatric urologic problems
- List current areas of controversy in the management of common problems including vesicoureteral reflux, hydronephrosis, and hypospadias
|
|
| 10:15 AM |
Viewing Time |
| 10:30 AM |
P22. Prenatally Diagnosed Solitary Kidneys: Is Serial Evaluation With Repeated Ultrasounds Required? Paul A. Merguerian, MD, FAAP Dartmouth-Hitchcock Medical Center, Lebanon, NH |
| 10:33 AM |
P23. Factors Involved in Parental Decision-making for Surgical Correction of Vesicoureteral Reflux Pamela Ellsworth, MD1, Katherine Callaghan2, Eileen Gray, NP3, Anthony Caldamone1 1Brown University, Providence, RI; 2University of Massachusetts Medical School, Worcester, MA, USA; 3University Urological Associates, Inc, Providence, RI; |
| 10:36 AM |
P24. Establishment of New Nomograms for Predicting Resolution of Vesicoureteral Reflux Carlos R. Estrada, MD1, Carlo C. Passerotti, MD1, Dionne Graham, PhD 1, Craig A. Peters, MD2, Ilina Rosoklija, MS 1, Aimee Baysinger, BA 1, Samuel H. Eaton, MD1, Alan B. Retik, MD1, Hiep T. Nguyen, MD1 1Children's Hospital Boston, Boston, MA, USA; 2University of Virginia, Charlottsville, VA; |
| 10:39 AM |
P25. Early Spinal Cord Untethering and Anorectal Malformation Reconstruction Does Not Adversely Effect Lower Urinary Tract Function Carlos R. Estrada, MD1, Ali Dokucu, MD1, Joseph G. Borer, MD1, Shahram Koshbin, MD2, Stuart B. Bauer, MD1 1Children's Hospital Boston, Boston, MA; 2Brigham and Women's Hospital, Boston, MA |
| 10:42 AM |
P26. Distal Hypospadias Repair Using The Modified Snodgrass Technique: Parameters For A Successful Outcome Paul A. Merguerian, MD, FAAP1, Kwabena Pobi, MD1, Daniel Herz, MD, FAAP2 1Dartmouth-Hitchcock Medical Center, Lebanon, NH; 2Mt Sinai School of Medicine, New York City, NY; |
| 10:45 AM |
P27. Fibroepithelial Polyps of the Penis in Children Brian H. Eisner, MD, Patricio C. Gargollo, MD, Marc Cendron, MD, Craig A. Peters, MD, Antonio Perez-Atayde, MD, David A. Diamond, MD Children's Hospital Boston, Boston, MA |
| 10:48 AM |
P28. Testicular Self-Examination: Education And Tutorial Andrew Horowitz, BS1, Edward R. Feller, MD2, Anthony A. Caldamone, MD3 1Brown Medical School, Providence, RI; 2Brown Medical School -Bio Med Community Health, Providence, RI, USA; 3Division of Pediatric Urology, Hasbro Children’s Hospital, Providence, RI; |
| 10:51 AM |
P29. Surgical Experience Reduces the Risk of Complications in Children Undergoing Laparoscopic Urological Surgery Carlo C. Passerotti, MD1, Hiep T. Nguyen, MD1, Alan B. Retik, MD1, Craig A. Peters, MD2 1Harvard Medical School, Boston, MA; 2University of Virginia, Charlottesville, VA; |
| 10:54 AM |
P30. Robotic-Assisted Laparoscopic Ileal Bladder Augmentation Carlo C. Passerotti, MD1, Hiep T. Nguyen, MD1, Alberto Lais, MD2, Richard Lee, MD1, Carlos Estrada, MD1, Alan B. Retik, MD1, Craig A. Peters, MD3 1Harvard Medical School, Boston, MA; 2Bambino Gesu Children's Hospital, Rome, Italy; 3University of Virginia, Charlottesville, VA; |
| 10:57 AM - 11:20 AM |
|
Discussion |
| 11:20 AM |
|
Invited Guest Speaker
Overcoming Innumerable Obstacles: How to be a Successful Urologist in the 21st Century Gordon Smith, Esq. Manchester, ME |
| 12:00 PM |
|
Adjourn |
| 12:00 PM - 12:30 PM |
|
Annual Business Meeting |
| 12:30 PM - 1:30 PM |
|
Lunch In Exhibit Hall |
| 12:30 PM - 1:30 PM |
|
Lunch Symposium |
| 1:30 PM |
|
Introduction Of Wyland F. Leadbetter Memorial Lecturer |
| 1:35 PM |
|
Wyland F. Leadbetter Memorial Lecturer Alan B. Retik, MD Boston Children’s Hospital Boston, MA |
| 2:20 PM - 3:30 PM |
|
Concurrent Scientific Session V: Pediatrics
Educational Objectives:
At the conclusion of this session the participants will be able to:
- Describe state-of-the-art diagnostic and therapeutic options for both common and complex pediatric urologic problems
- List current areas of controversy in the management of common problems in pediatric urology
|
|
| 2:20 PM |
27. Strep and Urinary Frequency: Is There a Connection? Christina Kim, MD1, Steven G. Docimo, MD2, Kathleen McKay, PhD1. 1Connecticut Children's Medical Center, Hartford, CT, USA; 2University of Pittsburgh, Pittsburgh, PA, USA; |
| 2:27 PM |
28. Antenatal Hydronephrosis as a Predictor of Postnatal Outcome: A Meta- Analysis Richard S. Lee, MD1, Marc Cendron, MD1, Daniel D. Kinnamon, MS2, Hiep T. Nguyen, MD1 1Children's Hospital Boston, Boston, MA; 2University of Miami, Miami, FL; |
| 2:34 PM |
29. Renal Parenchymal Thickness on Computed Tomography May Predict Renal Function in Obstructed Renal Units: Is a Nuclear Renogram Necessary? Daniel M. Kaplon, MD, Gyan Pareek, MD, David Bae, MD. Brown University, Providence, RI |
| 2:41 PM |
30. The Proteomic Analysis of Rat Urine as a Discovery Method of Urinary Biomarkers of Postnatal Maturation and Renal Obstruction Richard S. Lee, MD, Flavio Monigatti, PhD, Mohini Lutchman, PhD, Judith A.J. Steen, PhD, Michael R. Freeman, PhD, Hanno Steen, PhD Children's Hospital Boston, Boston, MA |
| 2:48 PM |
31. Initial Results Of Endoscopic Treatment Of Primary Vesicoureteral Reflux (VUR) With Dextranomer/Hyaluronic Acid (Deflux) In Single And Duplicated Systems Paul A. Merguerian, MD, FAAP1, Kwabena Pobi, MD1, Daniel Herz, MD2 1Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA; 2Mt Sinai Hospital Medical Center, New York, NY; |
| 2:55 PM |
32. Relationship of Grade and Hypotrophy to Semen Parameters in Boys with Adolescent Varicocele David A. Diamond, MD, Stuart B. Bauer, MD, Joseph G. Borer, MD, Craig A. Peters, MD, Bartley G. Cilento, Jr., MD, Alan B. Retik, MD, Ilina Rosoklija, MPH, David Zurakowski, PhD Children's Hospital, Boston, MA |
| 3:02 PM |
33. Reconstruction of Ureteral Anomalies Using Robotic-Assisted Laparoscopy Carlo C. Passerotti, MD1, Hiep T. Nguyen, MD1, David A. Diamond, MD1, Joseph Borer, MD1, Damian Sorce, MD2, Martin Koyle, MD2, Peter Furness, III, MD2, Stuart Bauer, MD1, Carlos Estrada, MD1, Alan B. Retik, MD1, Craig A. Peters, MD3 1Harvard Medical School, Boston, MA, USA; 2University of Colorado, Denver, CO, USA, 3University of Virginia, Charlottesville, VA, USA; |
| 3:09 PM - 3:30 PM |
|
Discussion |
| 2:20 PM - 3:15 PM |
|
Concurrent Poster Session IV: General (Including BPH, Infertility/impotence, Stones/endourology) Educational Objectives: At the conclusion of this session the participants will be able to:
- Describe current areas of research in voiding dysfunction, erectile dysfunction, and urolithiasis
- List novel pharmacologic agents undergoing investigation for voiding and erectile dysfunction
|
|
| 2:20 PM |
Viewing Time |
| 2:35 PM |
P31. Correlations Between Improvements in Patients’ Most Bothersome Overactive Bladder Symptoms and Patient-Reported Outcomes after Treatment with Tolterodine Extended Release David A. Gordon, MD1, Marina Brodsky, PhD2, Dale B. Glasser, PhD2, Karin S. Coyne, MPH, PhD3, Zhanna Jumadilova, MD, MBA2, Martin Carlsson, MS2 1Chesapeake Urology, Owings Mills, MD; 2Pfizer, Inc, New York, NY; 3United BioSource Corporation Center for Health Outcomes Research, Bethesda, MD; |
| 2:38 PM |
P32. Tamsulosin and Extended-Release Oxybutynin: Effects of Combination Therapy on Lower Urinary Tract Symptoms in Men Victor W. Nitti, MD1, Andrew Chen, MS2, Nora Tu, PhD2, Joseph W. Aquilina, MD3, Scott A. MacDiarmid, MD4 1New York University Medical College, New York, NY; 2Ortho-McNeil Pharmaceutical, Raritan, NJ; 3McNeil Consumer & Specialty Pharmaceuticals, Fort Washington, PA; 4Wake Forest University School of Medicine, Winston-Salem, NC; |
| 2:41 PM |
P33. Realise Study: Real Life Safety and Tolerability of Vardenafil in the Treatment of Men with Erectile Dysfunction Eric Cheng, MD, MPA SUNY in Brooklyn, Brooklyn, NY |
| 2:44 PM |
P34. Comparison of the FREDDY and Holmium Lasers for Laser Lithotripsy of Ureteral Calculi Jennifer K. Yates, MD, Gyan Pareek, MD, August Zabbo, MD Brown University, Providence, RI |
| 2:47 PM - 3:15 PM |
|
Discussion |
| 3:30 PM - 4:30 PM |
|
Panel Discussion: Common Issues in Adult and Pediatric Urology
| Invited Panelists: | Brian M. Jumper, MD Alan B. Retik, MD Pamela I. Ellsworth, MD David F. Green, MD Robert M. Weiss, MD |
|
| 4:30 PM - 4:45 PM |
|
Discussion |
| 4:45 PM |
|
Adjourn |
| 6:30 PM |
|
President’s Reception And Banquet - State House Rotunda & Governors State Room Business Attire |
|
|
|
|
|
|
| |
|
|
| |
|
|
|